Bioniche Life Sciences, Inc.

Canadian biotech firm's revenues increase in 1Q of fiscal 2005

Published in Pharma Investments, Ventures and Law Weekly, December 26th, 2004

Bioniche Life Sciences, Inc., (BNC), a research-based, technology-driven Canadian biopharmaceutical company, released first quarter results for fiscal 2005 (for the period ended September 30, 2004).

Consolidated revenues for the quarter increased 3.1% to $10.1 million from $9.8 million in the same period last year. Revenues from increased sales of the company's proprietary product for the treatment of cystitis in humans - Cystistat - contributed to this increase. Sales were negatively impacted by $0.4 million due to currency fluctuations.

"Cystistat is beginning to show its potential for us, particularly in Canada and Europe," stated Graeme McRae,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2004-12-26)

More Articles from Pharma Investments, Ventures and Law Weekly

Acambis plc
Pharma company releases third quarter 2004 results
Access Pharmaceuticals, Inc.
Pharmaceutical company reports loss of $0.16 per share
Alchemia Limited
Pharma company discusses financial results
Amgen, Inc.
Biotech company announces offer of $2B in two series of senior notes
Antares Pharma, Inc.
Pharmaceutical firm reports loss of $0.06 per share
Astralis, Ltd.
Biotech company reports loss of $0.02 per share
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry